This HTML5 document contains 112 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
n11	http://dx.doi.org/10.1185/
schema	http://schema.org/
rdfs	http://www.w3.org/2000/01/rdf-schema#
skos	http://www.w3.org/2004/02/skos/core#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
n6	https://w3id.org/oc/corpus/br/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n12	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q28244610

rdf:type

wikibase:Item

schema:description

2011年论文 artigo científico vitskapeleg artikkel article científic wissenschaftlicher Artikel artykuł naukowy wetenschappelijk artikel (gepubliceerd in 2011-09) 2011年論文 teaduslik artikkel 2011年の論文 artículo científico publicado en 2011 article scientific სამეცნიერო სტატია научни чланак 2011年论文 artikulong pang-agham 2011 nî lūn-bûn articol științific επιστημονικό άρθρο мақолаи илмӣ 2011年论文 2011年論文 scienca artikolo мақолаи илмӣ 2011年論文 mokslinis straipsnis наукова стаття, опублікована у вересні 2011 2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած 2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված 2011年论文 научни чланак научна статия ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ מאמר מדעי artigo científico 2011年论文 bài báo khoa học vetenskaplig artikel 2011年論文 artigo científico vitenskapelig artikkel vedecký článok (publikovaný 2011-09) artículu científicu espublizáu en 2011 scientific article (publication date: September 2011) tieteellinen artikkeli บทความทางวิทยาศาสตร์ 2011年論文 vědecký článek publikovaný v roce 2011 videnskabelig artikel 2011년 논문 articolo scientifico artikull shkencor 2011年论文 مقالة علمية (نشرت في سبتمبر 2011) bilimsel makale naučni članak tudományos cikk article scientifique научная статья

p:P577

wds:Q28244610-B9BE0C3D-8ADA-48CE-8357-EAB9FF1D72F5

wdt:P577

2011-09-01T00:00:00Z

p:P407

wds:Q28244610-AC4ACCCE-1AA7-4B20-8A68-B0CA7FB786D0

wdt:P407

wd:Q1860

p:P2093

wds:Q28244610-C006520A-B5D7-4CA3-BC1B-03BB4B1E29D6 wds:Q28244610-6A5C68EC-25F5-4F1B-88A1-ADCCF042731C wds:Q28244610-6390B547-EFA2-4B1C-991B-F99DBC5CC603 wds:Q28244610-970F4414-E2C8-4387-8D7B-18D44C9F3FD5 wds:Q28244610-4CCFA613-4650-4298-9FC6-D8A5489389F4

p:P3181

wds:Q28244610-5FD4D684-971D-4F05-A430-4CABB4BDBEFA

wdtn:P3181

n6:2677399

wdt:P2093

Masashi Hirayama Shinzo Hiroi Tetsuya Fujita Yutaka Seino Kohei Kaku

wdt:P3181

2677399

rdfs:label

Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study

skos:prefLabel

Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study

schema:name

Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study

p:P1476

wds:Q28244610-15B8079C-194F-451F-AAB0-86B9F5486189

wdt:P1476

Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study

p:P304

wds:Q28244610-BC6953AB-EC4C-44D9-945E-D8A43A444784

wdt:P304

1781-92

p:P31

wds:Q28244610-0D1F794D-A4A1-4B62-98AC-185FE466ADEC

wdt:P31

wd:Q13442814

p:P921

wds:Q28244610-C6B54610-C3E9-4944-B57C-8089C1391690 wds:Q28244610-C76FEDBF-4832-4831-8A5D-38FB1083B6E1 wds:Q28244610-CA4E0E9E-74C9-4E0B-8F17-4E2E420BAB54 wds:Q28244610-EAABA34E-E0FA-49BA-AF95-B35BAB8AFACE

wdt:P921

wd:Q269829 wd:Q4734170 wd:Q3025883 wd:Q181600

p:P698

wds:Q28244610-6A096DC0-619E-42D2-BBA4-1CCD26814609

wdtn:P698

n12:21806314

wdt:P698

21806314

p:P1433

wds:Q28244610-87878749-81AB-4E30-B49E-71544AF1AD39

wdt:P1433

wd:Q5195063

p:P433

wds:Q28244610-005BCBAD-02E4-49B9-96E2-CC6A533E8DE9

p:P478

wds:Q28244610-17415589-F7DE-4B59-92A2-190B804D6D69

wdt:P433

9

wdt:P478

27

p:P356

wds:Q28244610-B38CC705-21E7-4A81-9DD5-C1E9DCE3E7B2

wdtn:P356

n11:03007995.2011.599371

wdt:P356

10.1185/03007995.2011.599371